MedTrace Logo

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

NCT06519162 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2026-03-20

No results posted yet for this study

Summary

In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.

Conditions

  • Autoimmune Hepatitis
  • Primary Sclerosing Cholangitis
  • Non-Alcoholic Fatty Liver Disease
  • Liver Abscess
  • Primary Biliary Cirrhosis

Sponsors & Collaborators

  • Chungnam National University

    collaborator OTHER

  • Chungnam National University Hospital

    lead OTHER

Principal Investigators

  • Hyuksoo Eun · Chungnam National University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-08
Primary Completion
2029-07-08
Completion
2029-07-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06519162 on ClinicalTrials.gov